BioCentury
ARTICLE | Clinical News

Trulicity dulaglutide: Phase III data

July 25, 2016 7:00 AM UTC

The double-blind, international Phase III AWARD-9 trial in 300 Type II diabetics showed that once-weekly 1.5 mg Trulicity as an add-on to Lantus insulin glargine met the primary endpoint of reducing ...